Stock Information
Xenon Pharmaceuticals Inc (XENE)
Ticker Symbol: XENE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $5,775.77 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -4.74
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -43.98%
Latest News
-
Guggenheim Assumes Xenon Pharmaceuticals at Buy, Announces Price Target of $73
Tue, Oct 6, 2026 8:12 AM
-
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fri, Oct 2, 2026 8:01 PM
-
Xenon’s Insider Buying Tops $1.6M – XENE Stock Heads For Best Day In Over Month
Thu, Oct 1, 2026 4:10 PM
-
Xenon's AZK Approval Path Unlikely to Be Hurt by Safety Issues, RBC Says
Thu, Oct 1, 2026 3:02 PM
Key Financials
Financial data not available
